U.K. Drug for Abuse Testing Devices Market, by Product Type (Immunoassay Analyzers, Chromatography Instruments, Breathalyzers (Semiconductor-based Breathalyzer, Infrared (IR) Based Breathalyzer, and Fuel Cell-based Breathalyzer), Oral Fluid Testing Device

U.K. Drug for Abuse Testing Devices Market, by Product Type (Immunoassay Analyzers, Chromatography Instruments, Breathalyzers (Semiconductor-based Breathalyzer, Infrared (IR) Based Breathalyzer, and Fuel Cell-based Breathalyzer), Oral Fluid Testing Devices, Urine Testing Devices (Drug Testing Cup, DIP Cards, and Drug Testing Cassettes) , and Consumables (Assay Kits, Calibrators and Controls, and Others)), by Sample Type (Urine, Breathe, Saliva, Hair, and Others), and by End User (Hospitals, Federal Departments, Rehabilitation Centers, Diagnostic Laboratories, Academic Institutes and Research Centers, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Drug for abuse are illegal drugs consumed for the non-medication purpose for longer period of time. Drugs of abuse testing is performed both for medical purposes and legal causes such as workplace drug testing. The test for drug for abuse include immunoassay to screen different samples and the confirmation of screening results by definitive analytical techniques such as spectrometry and chromatography. Illicit drugs include cocaine, amphetamines, heroin, and hallucinogens are substances that can inhibit the central nervous system and cause hallucinogenic effects. The key end users in drug for abuse testing market include hospitals, diagnostic laboratories, federal departments, and rehabilitation centers. Some of the other end users are academic institutes and research laboratories.
Market Dynamics
The increasing production and trade of illicit drugs, rise in road accidents and death rates, increase in the consumption of illegal drugs, and growing government initiatives to reduce the incidence of driving under influence of drugs and alcohol are the factors that are driving growth of the market. For instance, according to data by the National Health Services, the number of hospital admissions in England for heroin or other opioid poisoning increased by 121%, since the past 12 years (2006-2018). The number of patients were around 7,258 in the year 2017-2018. Furthermore, According to the press release by Gov. UK in July 2017, the Home Secretary has launched the government’s new drug strategy, to reduce illicit drug use and increase the rate of individuals recovering from drug dependence. The new strategy confronts these threats and sets out new action to protect the most vulnerable, including the homeless, victims of domestic abuse and those with mental health issues.

Key features of the study:
This report provides in-depth analysis of the U.K. drug for abuse testing device market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the U.K. drug for abuse testing device market based on the following parameters – Company Highlights, Product Types Portfolio, Key Highlights, Financial Performance, and Market Strategies

Key companies covered as a part of this study include Abbott Laboratories, Thermo Fisher Scientific, Inc, Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics, Alfa Scientific Designs, Inc, Lifeloc Technologies Inc, Lion Laboratories Limited, OraSure Technologies, Inc, Omega Laboratories, Inc., Shimadzu Corporation, Siemens Healthineers, F. Hoffmann-La Roche AG, Premier Biotech, Inc, Psychemedics Corporation, Innovative Testing Solutions, Biopanda Reagents Ltd, Alpha Laboratories, Matrix Diagnostics, Atlas Medical, Rapid Labs Limited, and Randox Laboratories Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The U.K. drug for abuse testing device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.K. drug for abuse testing device market

Detailed Segmentation:
U.K. Drug for Abuse Testing Device Market, By Product Type:
Immunoassay Analyzers
Chromatography Instruments
Breathalyzers
Semiconductor-based Breathalyzer
Infrared (IR) Based Breathalyzer
Fuel Cell-based Breathalyzer
Oral Fluid Testing Devices
Urine Testing Devices
Drug Testing Cups
DIP Cards
Drug Testing Cassettes
Consumables
Assay Kits
Calibrators and Controls
Others
U.K. Drug for Abuse Testing Device Market, By Sample Type:
Urine
Breathe
Saliva
Hair
Others
U.K. Drug for Abuse Testing Device Market, By End user:
Hospitals
Federal Departments
Rehabilitation Centers
Diagnostic Laboratories
Academic Institutes and Research Centers
Others
Company Profiles
Abbott Laboratories*
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Market Strategies
Thermo Fisher Scientific, Inc
Drägerwerk AG & Co. KGaA
Laboratory Corporation of America Holdings
Quest Diagnostics
Alfa Scientific Designs, Inc
Lifeloc Technologies Inc.
Lion Laboratories Limited
OraSure Technologies, Inc.
Omega Laboratories, Inc.
Shimadzu Corporation
Siemens Healthineers
F. Hoffmann-La Roche AG
Premier Biotech, Inc.
Psychemedics Corporation
Innovative Testing Solutions
Biopanda Reagents Ltd
Alpha Laboratories
Matrix Diagnostics
Atlas Medical
Rapid Labs Limited
Randox Laboratories Ltd
* marked represents similar segmentation in other categories in the respective section.